On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease. Scientists, practitioners, and patient advocates discussed two EASL…
Save the date and register for the first webinar. Free access. Topic: Sarcopenia in chronic liver disease When: Thursday, 12th Nov. 2020 from 8 pm to 9.30 pm CET Learning objectives: To gain an understanding of the pathophysiology of sarcopenia…
From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster the next generation of bright minds. Are you a young scientist on a dynamic career…
5 October 2020 The Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton, and Charles M. Rice for the discovery of hepatitis C virus The 2020 Nobel Prize for Physiology and Medicine…
This week, 7-13 September, marks the 2020 Global Week for Action on NCDs (non-communicable diseases). The campaign draws on energy, inspiration, determination, optimism, and outrage to focus efforts on ensuring NCD prevention and control get the attention and action they…
It is with great sadness that EASL announces the passing of Prof. Christiaan Hendrik (Chris) Gips, a pioneer in liver transplantation, patient empowerment, and education in the field of hepatology. His work was characterised by great vision and intelligence. Prof.…
At Digital ILC 2020, EASL is launching a policy paper with its accompanying lay summary about drug use and the global hepatitis C elimination goal. WHO has set a goal of eliminating the hepatitis C virus (HCV) by 2030 but…
At Digital ILC 2020, EASL planned to give a Recognition Award to Prof. Roger Williams to honour his lifelong contribution to hepatology. Sadly, Prof. Williams passed away just a month before he was to receive it. He had already recorded…
I am proud to welcome you to this immersive event and for continuing to share knowledge and the very latest in research. This innovative congress is bringing members of the worldwide liver community together to: LEARN, INTERACT AND SHARE. Thank…
At Digital ILC 2020, EASL is launching a policy paper with its accompanying lay summary, to inform politicians, policymakers, and the general population about the two leading causes of liver disease in Europe: non-alcoholic fatty liver disease (NAFLD) and alcohol-related…